TGM4 anticorps (AA 13-17)
Aperçu rapide pour TGM4 anticorps (AA 13-17) (ABIN871754)
Antigène
Voir toutes TGM4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 13-17
-
Specificité
- The antibody detects endogenous levels of total DP-1 protein.
-
Purification
- Affinity purified
-
Immunogène
- Peptide sequence around AA 13-17 (E-L-K-V-F) derived from Human DP-1 Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
-
-
-
Indications d'application
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- TGM4 (Transglutaminase 4 (Prostate) (TGM4))
-
Autre désignation
- DP-1
-
Sujet
- Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DP2/E2F complex functions in the control of cell-cycle progression from G1 to S phase. The E2F-1/DP complex appears to mediate both cell proliferation and apoptosis.
-
Poids moléculaire
- 45 kDa
-
ID gène
- 7027
-
NCBI Accession
- NP_009042
-
UniProt
- Q14186
Antigène
-